High Flow Nasal Cannula Oxygen Therapy for Acute Carbon Monoxide Poisoning

Carbon monoxide is a silent, invisible threat that forms whenever fuel like coal, gas, or gasoline burns without enough air. It is odorless and colorless, making it impossible to detect without special equipment. When a person breathes this gas in, it slips into the bloodstream and latches onto the red blood cells that usually carry oxygen to the body's tissues. Because carbon monoxide holds on to these cells much more tightly than oxygen does, it blocks the delivery of life-sustaining air to the brain and organs. This blockage causes a state of suffocation at the cellular level, leading to headaches, nausea, confusion, and in severe cases, permanent brain damage or death. The standard way to treat this poisoning has long been to flood the lungs with pure oxygen, often using a high-pressure chamber to force the gas out of the blood faster. However, these chambers are expensive, rare, and not always available when a patient needs help immediately.

A team of doctors at Shanghai Fourth People's Hospital recently explored a different approach for patients who have been exposed to dangerous levels of this gas but have not lost consciousness. They turned to a device called a high-flow nasal cannula, which delivers a steady stream of warm, humidified oxygen directly into the nose at a very high speed. In a small study published in late 2024, the researchers treated five patients who had been found in enclosed spaces with high concentrations of carbon monoxide. All five patients arrived with severe headaches and nausea, and their blood tests showed that nearly one-third of their red blood cells were occupied by the poisonous gas. Instead of waiting for a hyperbaric chamber, the medical team immediately placed them on the high-flow oxygen device, setting it to deliver sixty liters of air per minute with one hundred percent oxygen.

The results were swift and consistent. Within the first hour of treatment, the levels of carbon monoxide in the blood of one patient had already dropped to a safe range. By the three-hour mark, every single patient in the group had cleared the poison from their blood to normal levels. The doctors monitored the patients closely, checking their blood gases every hour at first, then less frequently as the numbers stabilized. After five days of this high-flow treatment, the patients were switched to a standard, low-flow oxygen tube for four more days before going home. Throughout their stay and during a follow-up three months later, none of the patients showed signs of lasting brain injury. Tests designed to measure memory, attention, and thinking skills remained normal, and standard brain scans taken shortly after admission and again months later showed no visible damage.

Beyond the blood tests and brain scans, the researchers also looked at specific proteins in the blood that act as warning signs for brain stress. One of these, a protein called neuron-specific enolase, which rises when brain cells are injured, was significantly higher when the patients first arrived but dropped to normal levels after treatment. Similarly, the counts of red blood cells and hemoglobin, which had been elevated likely due to the body's reaction to the initial poisoning, returned to normal ranges. The study suggests that this high-speed oxygen method is a fast, safe, and effective way to treat moderate carbon monoxide poisoning, offering a powerful alternative for hospitals that do not have access to high-pressure chambers. While the group of patients was small, the speed at which the poison was removed and the lack of long-term side effects provide a clear path forward for how emergency rooms might handle these cases in the future.